A genetic predisposition of humans to paralytic poliomyelitis has long been suspected (2, 26, 33) ; however, the nature of the putative genetic component remains unclear. Twin and pedigree studies have suggested that autosomal recessive genes are associated with susceptibility to paralytic poliomyelitis (1, 10, 30) , although dominant-gene inheritance for disease susceptibility has also been noted (41) . Analyses of the role of the major histocompatibility complex in paralytic-poliomyelitis susceptibility have also given variable results, with one report of a significant association with HLA-A3 and HLA-A7 (28) which was not confirmed (8, 20, 42) and a report of association of HLA-encoded genetic factors with resistance rather than susceptibility (36) . Indeed, we previously reported differences between two inbred mouse strains in their cell-mediated immune responses to peripheral inoculation of the poliovirus type 2 W-2 strain (PV2/W-2) (37) . However, our further investigation using 17 different mouse strains did not reveal a correlation between cell-mediated immune responses and H-2 haplotype (38) . Our present study of disease susceptibility and pathogenesis of poliovirus-induced paralysis in inbred mice of different H-2 haplotypes indicates variation in susceptibility to the attenuated PV2/W-2 strain but not to the virulent Lansing (PV2/Lansing) strain. Susceptibility to PV2/W-2-induced paralysis did not correlate with H-2 haplotype but appeared to correlate with the non-H-2 genes of the DBA mouse strains, an inability to produce neutralizing antibodies, and the rapid spread and replication of virus in the central nervous system. In contrast, all three H-2k mouse strains examined had a low incidence of disease.
To determine their susceptibility to disease, 10 strains of inbred mice were inoculated intracerebrally (i.c.) with 0.02 strains were used, since PV strains of varied neurovirulence exist in nature (25, 33) and highly virulent strains can override host genetic factors and mask susceptibility or resistance (24, 32) . Six-week-old, barrier-free male mice were used. A/J, AKR/J, B1O.D2/J, C57BL/1OJ (B10), CBA/J, C3H/HeJ, DBA/1J (Dl), and DBA/2J (D2) mice were purchased from the Jackson Laboratory, Bar Harbor, Maine; BALB/c mice were purchased from Cumberland View Farms, Clinton, Tenn.; and CD-1 Swiss mice were purchased from Charles River, Portage, Mich. Mice were observed daily for paralysis and death through day 30 postinfection (p.i.). The cumulative percentage of paralysis and death was calculated from the total number of mice paralyzed plus the mice that died without over paralysis (nonparalytic death). Paralysis and nonparalytic death were combined because all paralyzed mice die and less than 5% of mice die without observed paralysis (14, 16) . Statistical analysis of disease incidence plus time to disease onset was determined by the life table method (27) by using the times to paralysis and to nonparalytic death as life table endpoints. Nine statistically independent comparisons (35) were made, and each was tested for significance with 1 df by using the log rank test (27) A marked variation in susceptibility to paralysis and death in mice inoculated with PV2/W-2 was observed ( Table 1 , Fig. 1 ). The Dl and D2 mice, which share a large number of non-H-2 genes because of their relatively recent common origin (3), had the highest incidence of paralysis and death, whereas the other strains had comparatively low to intermediate incidence rates. The Dl and D2 mice had significantly higher incidences of paralysis and death than the other mouse strains (P < 0.005). These two strains did not differ significantly from each other with respect to disease incidence. The values for strains with intermediate incidences of paralysis and death (A/J, B10, and BALB/c) were significantly different from those for the strains with low incidences (CD-1, B1O.D2/J, AKR/J, C3H/HeJ, and CBA/J) (P < 0.005). All H-2k haplotype strains tested had low incidence rates. No statistically significant differences were detected among the strains with intermediate incidences or among those with low incidences of paralysis and death.
Little variation in susceptibility was seen among mice infected with the virulent PV2/Lansing strain, as all strains had a very high incidence of paralysis and death (Table 2) . Because the virulent PV2/Lansing strain was invariably lethal in all mouse strains and because its pathogenesis has been previously analyzed (14, 15, 18) , no further experiments were undertaken with this virus. The invariable lethality of PV2/Lansing was not unexpected since this virus spreads rapidly throughout the nervous system, presumably by fast axonal transport (18) and does not induce a neutralizing-antibody response (14, 15, 22 PV2/Lansing also found this strain to be invariably fatal (34) .
To determine the basis of the observed variation in disease susceptibility to PV2/W-2, mice of each strain were inoculated i.c. with PV2/W-2 (107-4 TCD50s) and killed at regular intervals for central nervous system virus assays and T-cell proliferation (TPRLF) assays. Other mice were bled from the retro-orbital venous plexus at periodic intervals to obtain sera for antibody assays. For virus assays, brain (brain plus brainstem) and spinal cord tissues were prepared separately as 10% homogenates and stored at -70°C until assayed. Virus replication was assayed by a microtiter method (17) , and the TCD50 was calculated (29) . Three nonparalyzed mice were assayed at each time point, and the geometric means were calculated. Paralyzed mice were not assayed, since all such mice are known to have high virus titers in the spinal cord at the onset of paralysis (17, 18) . Virus replication in the brains of nonparalyzed mice rapidly peaked on day 1, 2, or 3 p.i., reaching levels of 4.5 to 6.0 log1o TCD50s/0.02 g of tissue for all strains analyzed (Table 3 ). In contrast, virus replication in the spinal cords of nonparalyzed mice reached high levels (>4.0 log1o TCD50s/0.02 g of tissue) in only four strains, Dl and D2 (high-incidence strains) and BALB/c and B10 (intermediate-incidence strains) ( Table 4) . In other strains, virus replication in the spinal cord was at lower levels. There was no obvious correlation between spinal cord virus replication and H-2 haplotype.
A correlation between paralysis and death and a high level of spinal cord virus replication after i.c. PV inoculation has been previously recognized (17, 18) and might reflect a more rapid spread of virus from the brain to the cord in some mouse strains or a greater susceptibility of cells in the spinal cord to infection. If virus actually spreads more rapidly to spinal cords in susceptible mice, then several possibilities exist. Some viruses, such as the arboviruses, are thought to spread through extracellular gaps in the neuropil (4) that communicate freely with the cerebrospinal fluid compartment (5) . Possibly some inbred mouse strains have larger extracellular gaps that allow virus in the cerebrospinal fluid easier access to anterior horn cells. However, our previous studies with Swiss mice gave no indication that the virulent PV2/Lansing strain spreads via the cerebrospinal fluid and extracellular gaps (18) . Also, in our studies with PV2/W-2, we found no evidence of infected arachnoid or meningeal cells, which would facilitate spread through the cerebrospinal fluid (16, 17) . Alternatively, virus spread might occur intracellularly via axonal transport, in which case highdisease-incidence mouse strains might have more efficient entry of PV into the transporting cells (via receptors), more efficient transport of virus, or more direct pathways to anterior horn cells. To our knowledge, no experimental evidence to support any of these possibilities exists.
Serum antibody responses were determined by both a microneutralization (13) and an indirect solid-phase enzymelinked immunosorbent assay (ELISA) method for the total antibody response (immunoglobulin M plus immunoglobulin G) (15) . The neutralizing-antibody response peaked early on day 4 in most strains and plateaued or gradually declined thereafter ( Table 5 ). The strains with the highest incidence of paralysis and death, i.e., Dl and D2, had the lowest levels of neutralizing antibody. There was no obvious correlation between neutralizing-antibody titers and H-2 haplotype. Thus, a second major factor apparently related to PV2/W-2-induced paralysis appears to be an impaired ability of a mouse strain to mount a neutralizing-antibody response. The importance of neutralizing antibody in preventing PV-induced disease is suggested by the observation that mice hyperimmunized to induce a serum neutralizing-antibody response to the virulent PV2/Lansing strain resist i.c. challenge with large doses of virus (14) . In addition, passive administration of hyperimmune serum prevents disease after i.c. inoculation with the PV2/Lansing strain (13a). Neutralizing antibody appears to be important for clearing PV from the central nervous system and preventing disease.
Mice of all strains, including the high-disease-incidence Dl and D2 mice, were capable of producing antibodies, as detected by the ELISA method (Table 6 ). In a previous variation in disease susceptibility (paralysis and death) in 10 study, a prominent ELISA antibody response was observed inbred strains of mice inoculated with the attenuated PV2/ in animals infected with PV2/Lansing, although neutralizing W-2 strain. Log rank analysis defined three categories (high, antibodies were not detected (15) . Thus, as is the case with intermediate, and low) of disease incidence in these mice. some other virus infections (12, 23, 39) Theiler's virus (6, 31) . In both virus infections, susceptibility previous study using antithymocyte serum to treat PVhas been shown to be under multigenic control by both infected BALB/c mice, which suggested a role for T cells in H-2-associated and non-H-2 genes (7, 21, 31, 40) . The lack of central nervous system viral clearance (19) . In addition, a neutralizing-antibody response in the Dl and D2 mice there was no correlation of TPRLF responses with H-2 might reflect control of this response by non-H-2 genes, haplotype. Still, the TPRLF responses were similar to those which are similar in these two strains. Further information found in our previous study (38) .
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